Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5 results about "Monosodium citrate" patented technology

Monosodium citrate, more correctly, sodium dihydrogen citrate (Latin: natrium citricum acidulatum), is an acid salt of citric acid. Disodium citrate and trisodium citrate are also known. It can be prepared by partial neutralisation of an aqueous solution of sodium bicarbonate or carbonate with citric acid.

Deep copper ion capture agent suitable for wide pH range, its preparation and application

This invention discloses a copper ion scavenging agent suitable for a wide pH range, its preparation method, and its application. The scavenging agent comprises the following components by mass: 10-30 parts trithiocarbonate, 5-20 parts N,N-dimethylaminodithiocarbamate, and 1-5 parts sodium citrate. The preparation method is as follows: (1) Add water to a sodium citrate solution and stir to prepare a buffer solution A; (2) Add trithiocarbonate and N,N-dimethylaminodithiocarbamate to buffer solution A, stir until completely dissolved, and filter to obtain the final product. This invention has the advantages of a wider pH range, copper removal effect that varies with water quality, stable copper removal effect, fast reaction speed, and rapid floc settling. After treatment, the concentration of each copper ion is less than 0.1 mg / L, the iron content is less than 0.0001%, and the lead content is less than 0.0001%, meeting the environmental emission requirements.
Owner:CHINA ELECTRONICS SYST ENG NO 2 CONSTR

High-stability oseltamivir phosphate dry suspension and preparation method thereof

The invention provides a high-stability oseltamivir phosphate dry suspension and a preparation method thereof, pharmaceutical raw materials are divided into three types and are subjected to dry granulation respectively, oseltamivir phosphate, sodium benzoate and sorbitol are used as medicine-containing particles for dry granulation, sorbitol, titanium dioxide and saccharin sodium non-medicine-containing particles are used for dry granulation, and the oseltamivir phosphate dry suspension is prepared. The sodium citrate, the sodium benzoate and the xanthan gum do not contain medicine particles and are subjected to dry granulation, so that contact between the oseltamivir phosphate raw materials and auxiliary materials and between the auxiliary materials is avoided, the negative reaction between the medicine components is remarkably reduced, and the medicine stability of the oseltamivir phosphate is improved. The preparation method is simple in process, low in power consumption and suitable for large-scale production and application of the oseltamivir phosphate dry suspension, the safety risk of solvent residues in wet granulation is avoided, the influence of mixing of whole raw materials in dry granulation on the property of oseltamivir phosphate is avoided, and the effectiveness of the medicine is improved.
Owner:HAINAN BRIGHT FUTURE PHARMA

Preparation method and preparation device of calcium dobesilate

The invention relates to the field of preparation of calcium dobesilate, and particularly discloses a preparation method of calcium dobesilate, which comprises the following steps: a, adding anhydrous sodium sulfite into water for dissolving to form an anhydrous sodium sulfite aqueous solution; b, sieving and refining mannitol, and then stirring and mixing the mannitol with the anhydrous sodium sulfite aqueous solution formed in the step a to form a mixture; c, drying the mixture obtained in the step b until the water content is less than 1%, and finishing the granules to obtain mannitol granules; d, uniformly mixing the calcium dobesilate, the mannitol particles and the monosodium citrate lubricant according to the amount to obtain mixed particles; e, tabletting the mixed particles obtained in the step d; the preparation method of the calcium dobesilate has the beneficial effect that the quality of the calcium dobesilate can be improved.
Owner:HUBEI GUANGCHEN PHARM CO LTD

Injection molding compound and use of injection molding compound

UndeterminedDE202025101490U1PolyesterPolymer science
Injection molding compound (2) comprising at least one polyester and a gas-releasing blowing agent mixture comprising: - monosodium citrate and - MgCO3 and / or CaCO3.
Owner:SCHWAN COSMETICS INT GMBH